290 related articles for article (PubMed ID: 33738333)
1. Impact of the COVID-19 pandemic on statistical design and analysis plans for multidomain intervention clinical trials: Experience from World-Wide FINGERS.
Röhr S; Arai H; Mangialasche F; Matsumoto N; Peltonen M; Raman R; Riedel-Heller SG; Sakurai T; Snyder HM; Sugimoto T; Carrillo M; Kivipelto M; Espeland MA;
Alzheimers Dement (N Y); 2021; 7(1):e12143. PubMed ID: 33738333
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS.
Rosenberg A; Mangialasche F; Ngandu T; Solomon A; Kivipelto M
J Prev Alzheimers Dis; 2020; 7(1):29-36. PubMed ID: 32010923
[TBL] [Abstract][Full Text] [Related]
5. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia.
Kivipelto M; Mangialasche F; Snyder HM; Allegri R; Andrieu S; Arai H; Baker L; Belleville S; Brodaty H; Brucki SM; Calandri I; Caramelli P; Chen C; Chertkow H; Chew E; Choi SH; Chowdhary N; Crivelli L; Torre R; Du Y; Dua T; Espeland M; Feldman HH; Hartmanis M; Hartmann T; Heffernan M; Henry CJ; Hong CH; Håkansson K; Iwatsubo T; Jeong JH; Jimenez-Maggiora G; Koo EH; Launer LJ; Lehtisalo J; Lopera F; Martínez-Lage P; Martins R; Middleton L; Molinuevo JL; Montero-Odasso M; Moon SY; Morales-Pérez K; Nitrini R; Nygaard HB; Park YK; Peltonen M; Qiu C; Quiroz YT; Raman R; Rao N; Ravindranath V; Rosenberg A; Sakurai T; Salinas RM; Scheltens P; Sevlever G; Soininen H; Sosa AL; Suemoto CK; Tainta-Cuezva M; Velilla L; Wang Y; Whitmer R; Xu X; Bain LJ; Solomon A; Ngandu T; Carrillo MC
Alzheimers Dement; 2020 Jul; 16(7):1078-1094. PubMed ID: 32627328
[TBL] [Abstract][Full Text] [Related]
6. The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol.
Xu X; Chew KA; Wong ZX; Phua AKS; Chong EJY; Teo CKL; Sathe N; Chooi YC; Chia WPF; Henry CJ; Chew E; Wang M; Maier AB; Kandiah N; Chen CL
J Prev Alzheimers Dis; 2022; 9(1):40-48. PubMed ID: 35098972
[TBL] [Abstract][Full Text] [Related]
7. Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.
Lorenc A; Rooshenas L; Conefrey C; Wade J; Farrar N; Mills N; Paramasivan S; Realpe A; Jepson M
Trials; 2023 Jun; 24(1):424. PubMed ID: 37349850
[TBL] [Abstract][Full Text] [Related]
8. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.
Barbera M; Lehtisalo J; Perera D; Aspö M; Cross M; De Jager Loots CA; Falaschetti E; Friel N; Luchsinger JA; Gavelin HM; Peltonen M; Price G; Neely AS; Thunborg C; Tuomilehto J; Mangialasche F; Middleton L; Ngandu T; Solomon A; Kivipelto M;
Alzheimers Res Ther; 2024 Jan; 16(1):23. PubMed ID: 38297399
[TBL] [Abstract][Full Text] [Related]
9. Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design.
Ponvel P; Shahar S; Singh DKA; Ludin AFM; Rajikan R; Rajab NF; Ai-Vyrn C; Din NC; Ibrahim N; Subramaniam P; Haron H; Ismail A; Sharif R; Ramasamy K; Majeed ABA; Ali NM; Mohamad M; Noah SAM; Ibrahim AM; Safien AM; Khalid NM; Fadzil NHM; Mangialasche F; Kivipelto M
J Alzheimers Dis; 2021; 82(2):673-687. PubMed ID: 34092633
[TBL] [Abstract][Full Text] [Related]
10. Multidomain interventions for risk reduction and prevention of cognitive decline and dementia: current developments.
Röhr S; Kivipelto M; Mangialasche F; Ngandu T; Riedel-Heller SG
Curr Opin Psychiatry; 2022 Jul; 35(4):285-292. PubMed ID: 35703256
[TBL] [Abstract][Full Text] [Related]
11. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe.
Tainta M; Ecay-Torres M; de Arriba M; Barandiaran M; Otaegui-Arrazola A; Iriondo A; Garcia-Sebastian M; Estanga A; Saldias J; Clerigue M; Gabilondo A; Ros N; Mugica J; Barandiaran A; Mangialasche F; Kivipelto M; Arrospide A; Mar J; Martinez-Lage P;
Alzheimers Res Ther; 2024 Feb; 16(1):44. PubMed ID: 38413990
[TBL] [Abstract][Full Text] [Related]
12. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
13. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
14. Multi-Domain Interventions for Dementia Prevention - A Systematic Review.
Castro CB; Costa LM; Dias CB; Chen J; Hillebrandt H; Gardener SL; Brown BM; Loo RL; Garg ML; Rainey-Smith SR; Martins RN; Sohrabi HR
J Nutr Health Aging; 2023; 27(12):1271-1280. PubMed ID: 38151879
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Lockdown Experiences and Views on Future Research Participation of Autistic Adults in the UK During the First 6 Months of the COVID-19 Pandemic.
Realpe AX; Mills N; Beasant L; Douglas S; Kenny L; Rai D
Autism Adulthood; 2023 Sep; 5(3):301-310. PubMed ID: 37663442
[TBL] [Abstract][Full Text] [Related]
18. Nonsomatic treatment of depression.
Sherrill JT; Kovacs M
Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trial.
Neuvonen E; Lehtisalo J; Solomon A; Antikainen R; Havulinna S; Hänninen T; Laatikainen T; Lindström J; Rautio N; Soininen H; Strandberg T; Tuomilehto J; Kivipelto M; Ngandu T
Aging Clin Exp Res; 2022 Aug; 34(8):1793-1805. PubMed ID: 35182352
[TBL] [Abstract][Full Text] [Related]
20. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
